{
    "nctId": "NCT02610426",
    "briefTitle": "Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer",
    "officialTitle": "Exploratory Next Generation Sequencing to Identify Causative Variants for Therapy-Induced Congestive Heart Failure From Breast Cancer Study E5103 Germline DNA Samples",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Carcinoma",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 162,
    "primaryOutcomeMeasure": "Identification of rare coding variants of large effect that predict the risk of CHF",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* European American patients with DNA available\n* European American patients who developed CHF and patients who did not develop CHF following a full course of treatment with an anthracycline and bevacizumab\n* African American cases (based on a drop in left ventricular ejection fraction \\[LVEF\\] \\< 50 or a drop from baseline \\> 20 points) and African American controls",
    "sex": "ALL",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}